Xenetic Biosciences, Inc. Annual Operating Margin in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Xenetic Biosciences, Inc. quarterly/annual Operating Margin history and growth rate from 2012 to 2023.
  • Xenetic Biosciences, Inc. Operating Margin for the quarter ending September 30, 2024 was -173 %, a 15.6% increase year-over-year.
  • Xenetic Biosciences, Inc. annual Operating Margin for 2023 was -178 %, a 54.8% increase from 2022.
  • Xenetic Biosciences, Inc. annual Operating Margin for 2022 was -394 %, a 20.5% increase from 2021.
  • Xenetic Biosciences, Inc. annual Operating Margin for 2021 was -495 %, a 84.5% increase from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -178 +216 +54.8% Jan 1, 2023 Dec 31, 2023
2022 -394 +102 +20.5% Jan 1, 2022 Dec 31, 2022
2021 -495 +2.69K +84.5% Jan 1, 2021 Dec 31, 2021
2020 -3.19K +72.3K +95.8% Jan 1, 2020 Dec 31, 2020
2019 -75.5K Jan 1, 2019 Dec 31, 2019
2017 -47.1 +1.53K +97% Jan 1, 2017 Dec 31, 2017
2016 -1.58K Jan 1, 2016 Dec 31, 2016
2013 -861 +1.3K +60.1% Jan 1, 2013 Dec 31, 2013
2012 -2.16K Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.